OncoImmunity
Business Services · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ullernchausséen 64, Oslo, Oslo, 0379, No...Phone Number
+47 90015242Website
www.oncoimmunity.comRevenue
<$5 MillionIndustry
About OncoImmunity
Is OncoImmunity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at OncoImmunity
Check if OncoImmunity has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on OncoImmunity recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OncoImmunity is spiking on competitors!
Product Launch: Get notified when OncoImmunity launches new products
OncoImmunity, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once OncoImmunity has new funding data
Website visits: Recent activity has been detected on your website
Click to see if OncoImmunity had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
OncoImmunity is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OncoImmunity is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoImmunity.
OncoImmunity Tech Stack
A closer look at the technologies used by OncoImmunity
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoImmunity
NEC Bio B.V. is dedicated to developing innovative therapies for patients worldwide, utilizing advanced AI technologies. The company focuses on personalized cancer vaccines and next-generation vaccines for infectious diseases, employing strategies that target specific tumor antigens and immunogenic pathogens. Their research includes collaborations... Read More